IL-17F

IL-17F

IL-17F Molekülinformation

Molecule Name
Interleukin-17F
Molekülalias
IL-17F,Interleukin-17F,Cytokine ML-1
Drug Development Progress
Anzahl der klinischen Arzneimittel5
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Target-Alias
Cytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
Molekülhintergrund
Interleukin-17F (IL17F) is also known as Interleukin-24 (IL24), Cytokine ML-1, is a secreted disulfide-linked homodimer which belongs to the IL-17 family. There are at least six members of the IL-17 family in humans and in mice: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also called IL-25) and IL-17F (also called IL-24). IL-17 represents a family of structurally related cytokines that share a highly conserved C-terminal region but differ from one another in their N-terminal regions and in their distinct biological roles. IL-17F / IL-24 is expressed in activated, but not resting, CD4+ T-cells and activated monocytes. IL17F / Interleukin-24 stimulates the production of other cytokines such as IL-6, IL-8 and granulocyte colony-stimulating factor, and can regulate cartilage matrix turnover. IL17F / IL-24 stimulates PBMC and T-cell proliferation and Inhibits angiogenesis. Defects in IL17F are the cause of familial candidiasis type 6 (CANDF6).

IL-17F Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
SonelokimabALX-0761; MSB-0010841; M-1095Phase 3 ClinicalAblynx Nv
Arthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis
Details
DMT-310DMT-310Phase 3 ClinicalDermata
Acne Vulgaris; Rosacea
Details
ORKA-002ORKA-002; PR-029; ORKA-021Phase 2 ClinicalParagon Therapeutics Inc
Arthritis, Psoriatic; Plaque psoriasis; Psoriasis
Details
PN-881PN-881Phase 1 ClinicalProtagonist Therapeutics Inc
Dermatitis; Psoriasis
Details
HY-1770HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770Phase 1 ClinicalSuzhou Pharmavan Co Ltd
Dermatitis, Atopic; Plaque psoriasis
Details